Medical Devices industry deals in October 2021: GlobalData
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Medical Devices industry deals total $6.2bn globally in October 2021

23 Nov 2021

Total medical devices industry deals worth $6.2bn were announced globally for October 2021, with the $1.75bn acquisition of Baylis MedicalInc being the sector’s biggest investment, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked an increase of 31.2% over the previous month of $4.74bn and a drop of 46.2% when compared with the last 12-month average of $11.55bn.

In terms of number of deals, the sector saw a drop of 26.90% with 125 deals in October 2021 when compared to the last 12-month average of 171 deals.

In value terms, North America led the activity with deals worth $4.66bn in October 2021.

medical devices industry deals in October 2021: Top deals

The top five deals accounted for 52.6% of the overall value during October 2021.

The combined value of the top five deals stood at $3.27bn, against the overall value of $6.2bn recorded for the month.

The top five medical devices industry deals of October 2021 tracked by GlobalData were:

1) Boston Scientific $1.75bn acquisition deal with Baylis Medical Inc

2) The $600m venture financing of Hinge Health by Alkeon Capital,Coatue Management,Tiger Global and Whale Rock Capital Management

3) 3D Systems $400m acquisition deal with Volumetric

4) The $304m venture financing of Medable by Blackstone,GSR Ventures,Sapphire Ventures,Tiger Global Management and Western Technology Investment

5) Integer $220m acquisition deal with Oscor

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.